Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Anthropic's Claude tools to compete or contribute to the healthcare sector, like OpenAI's ChatGPT Health!
Date 14 January 2026

Anthropic's Claude tools to compete or contribute to the healthcare sector, like OpenAI's ChatGPT Health!

Introduction A well-recognised AI research company, Anthropic, was founded by former OpenAI engineers who are keen to offer reliable, safe, and seamless artificial general intelligence for smart indi...

Nona's expanding initiatives to fuel modality solutions, tech platform and more
Date 13 January 2026

Nona's expanding initiatives to fuel modality solutions, tech platform and more

Introduction Nona Biosciences, a biotech entity along with its robust exclusive Harbour Mice® platform, is producing full-fledged human antibodies and has dug into AI-powered tools such as Hu-mAt...

BioVaxys's study results are out, featuring improvement of DPXâ„¢
Date 13 January 2026

BioVaxys's study results are out, featuring improvement of DPXâ„¢

Introduction BioVaxys Technology Corp. is a clinically devoted biotechnology company that promises to introduce novel immunotherapies involving antiviral vaccines and cancer. The company’s excl...

Lilly tightens its deals and accelerates its share buyout to bolster its Inflammatory Pipeline
Date 13 January 2026

Lilly tightens its deals and accelerates its share buyout to bolster its Inflammatory Pipeline

Introduction Eli Lilly is a person who named its pharmaceutical firm with the same name and shone for its high-quality medicines. Since 1876, Eli’s long-term vision and urge to introduce scienc...

Parabilis Medicines' million-dollar help to upgrade the Cancer Drug space
Date 13 January 2026

Parabilis Medicines' million-dollar help to upgrade the Cancer Drug space

Introduction Parabilis Medicines, formerly FogPharma, is a well-established clinical-level biopharma company passionate about developing effective peptide therapeutics known as Helicons. Helicon is l...

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial
Date 12 January 2026

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial

Introduction Protara Therapeutics, Inc. is a leading clinical-level biopharmaceutical company that has worked wonders in establishing life-changing, effective therapies for rare diseases and cancer. ...

ABS's buyout of Cureline's excellence to bolster biopharma drug discovery
Date 12 January 2026

ABS's buyout of Cureline's excellence to bolster biopharma drug discovery

Introduction ABS Bio, since its establishment in 1990, has delivered the best-in-class critical scientific relevant services involving tissue processing, cell culture, human biospecimens, biostorage ...

Jazz shows progress in stomach cancer with its promising findings
Date 12 January 2026

Jazz shows progress in stomach cancer with its promising findings

Introduction Jazz Pharmaceuticals, an Ireland-based company famous for its ‘Ziihera’ (zanidatamab), which is a prescription-based medicine have been serving a total of 75 countries with i...

Crinetics bets a million relying on its new Phase 2 results
Date 12 January 2026

Crinetics bets a million relying on its new Phase 2 results

Introduction Crinetics Pharmaceuticals is popular for discovering new medicines for curing endocrine-based diseases. The company came into force in 2008 with its regional origin in San Diego, Califor...

Novoron secured funding from NIH/NIA SBIR for its Alzheimer's Drug Discovery
Date 09 January 2026

Novoron secured funding from NIH/NIA SBIR for its Alzheimer's Drug Discovery

Announcement Novoron Bioscience, a well-known biotechnology company in San Diego since 2014, has been establishing new therapies for neurological injury and neurodegenerative diseases, and has now ea...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.